| Literature DB >> 28725745 |
Jean-Pol Frippiat1, Brian E Crucian2, Dominique J-F de Quervain3, Daniela Grimm4, Nicola Montano5, Siegfried Praun6, Benno Roozendaal7, Gustav Schelling8, Manfred Thiel9, Oliver Ullrich10, Alexander Choukèr8.
Abstract
Dysregulation of the immune system occurs during spaceflight and may represent a crew health risk during exploration missions because astronauts are challenged by many stressors. Therefore, it is crucial to understand the biology of immune modulation under spaceflight conditions in order to be able to maintain immune homeostasis under such challenges. In the framework of the THESEUS project whose aim was to develop an integrated life sciences research roadmap regarding human space exploration, experts working in the field of space immunology, and related disciplines, established a questionnaire sent to scientists around the world. From the review of collected answers, they deduced a list of key issues and provided several recommendations such as a maximal exploitation of currently available resources on Earth and in space, and to increase increments duration for some ISS crew members to 12 months or longer. These recommendations should contribute to improve our knowledge about spaceflight effects on the immune system and the development of countermeasures that, beyond astronauts, could have a societal impact.Entities:
Year: 2016 PMID: 28725745 PMCID: PMC5515533 DOI: 10.1038/npjmgrav.2016.40
Source DB: PubMed Journal: NPJ Microgravity ISSN: 2373-8065 Impact factor: 4.415
Figure 1Numerous dysregulations of the immune system have been reported during and following spaceflight. In parallel, spaceflight has been shown to increase the virulence, antibiotic resistance, and proliferation of some pathogens suggesting that susceptibility to infections could be enhanced during space missions.
Figure 2Interlinks between the central nervous system and the immune system. ANS, autonomic nervous system; IL, interleukin; PNS, peripheral nervous system; SNS, sympathetic nervous system; TNF-α, tumor necrosis factor α.